Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Medpace Holdings Inc (MEDP)

Medpace Holdings Inc (MEDP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 14,867,295
  • Shares Outstanding, K 28,558
  • Annual Sales, $ 2,530 M
  • Annual Income, $ 451,120 K
  • EBIT $ 563 M
  • EBITDA $ 591 M
  • 60-Month Beta 1.39
  • Price/Sales 5.82
  • Price/Cash Flow 30.31
  • Price/Book 31.64

Options Overview Details

View History
  • Implied Volatility 58.18% (-2.12%)
  • Historical Volatility 37.00%
  • IV Percentile 92%
  • IV Rank 73.44%
  • IV High 69.52% on 04/21/25
  • IV Low 26.83% on 08/15/25
  • Expected Move (DTE 25) 26.88 (5.09%)
  • Put/Call Vol Ratio 1.69
  • Today's Volume 43
  • Volume Avg (30-Day) 28
  • Put/Call OI Ratio 1.15
  • Today's Open Interest 917
  • Open Int (30-Day) 944
  • Expected Range 501.56 to 555.32

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $3.74
  • Number of Estimates 3
  • High Estimate $3.86
  • Low Estimate $3.60
  • Prior Year $3.67
  • Growth Rate Est. (year over year) +1.91%

Price Performance

See More
Period Period Low Period High Performance
1-Month
448.29 +17.88%
on 03/30/26
530.97 -0.48%
on 04/16/26
+75.93 (+16.78%)
since 03/20/26
3-Month
392.35 +34.69%
on 02/12/26
624.00 -15.31%
on 01/21/26
-73.96 (-12.28%)
since 01/20/26
52-Week
250.05 +111.33%
on 04/22/25
628.92 -15.98%
on 01/16/26
+232.16 (+78.36%)
since 04/17/25

Most Recent Stories

More News
Robbins LLP Urges Investors Who Lost Money Investing in Medpace Holdings Inc. to Contact the Firm for Information About Leading the Class Action Against MEDP

Robbins LLP  reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Medpace Holdings Inc. (NASDAQ: MEDP) securities between April 22,...

MEDP : 528.44 (+1.51%)
Medpace Holdings, Inc. (MEDP) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

LOS ANGELES , April 16, 2026 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Medpace Holdings, Inc. ("Medpace" or the "Company") (NASDAQ: MEDP...

MEDP : 528.44 (+1.51%)
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Medpace Holdings, Inc. of Class Action Lawsuit and Upcoming Deadlines - MEDP

NEW YORK , April 16, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Medpace Holdings, Inc. ("Medpace" or the "Company") (NASDAQ: MEDP).   Such...

MEDP : 528.44 (+1.51%)
MEDP INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Medpace (MEDP) Investors of Securities Class Action Deadline on June 8, 2026

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Medpace To Contact Him Directly To Discuss Their Options

MEDP : 528.44 (+1.51%)
MEDP Investor Alert: Medpace Holdings Inc. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Defendants Allegedly Violated Securities Disclosure Laws: SueWallSt

Deadline Alert: Understanding Lead Plaintiff Selection Under the PSLRA

MEDP : 528.44 (+1.51%)
MEDP INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Medpace Holdings Inc. Investors with Substantial Losses Have Opportunity to Lead Action Lawsuit

SAN DIEGO , April 15, 2026 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Medpace Holdings Inc. (NASDAQ: MEDP) common stock between April 22,...

MEDP : 528.44 (+1.51%)
MEDP Investor Alert: Medpace Holdings Inc. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Company Allegedly Concealed Backlog Deterioration: Levi & Korsinsky

Notice to Pension Funds, Asset Managers, and Fiduciaries

MEDP : 528.44 (+1.51%)
Deadline Alert: Medpace Holdings, Inc. (MEDP) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit

 

MEDP : 528.44 (+1.51%)
MEDP Investors Have Opportunity to Lead Medpace Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm

LOS ANGELES , April 14, 2026 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Medpace Holdings,...

MEDP : 528.44 (+1.51%)
Medpace Holdings, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MEDP

LOS ANGELES , April 14, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Medpace Holdings, Inc. ("Medpace" or "the Company") (NASDAQ: MEDP) for violations...

MEDP : 528.44 (+1.51%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio.

See More

Key Turning Points

3rd Resistance Point 547.98
2nd Resistance Point 539.03
1st Resistance Point 533.73
Last Price 528.44
1st Support Level 519.49
2nd Support Level 510.54
3rd Support Level 505.25

See More

52-Week High 628.92
Last Price 528.44
Fibonacci 61.8% 484.19
Fibonacci 50% 439.48
Fibonacci 38.2% 394.78
52-Week Low 250.05

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.